Search Results

Site Search

Genetic liver disease - Insights

Identifying underlying genetic disorders plays an important role in the treatment and care of patients with liver disease. Appropriate use of screening tests in routine clinical practice can rule out possible causes of liver disease and...

Viral Hepatitis Testing - Mayo Clinic Laboratories

At Mayo Clinic, we utilize an algorithmic approach to testing that takes the guesswork out of test ordering to focus on proper test utilization, saving your institution time and money.

Mosquito-borne disease - Insights

View our comprehensive menu of individually orderable tests and panels for mosquito-borne diseases and our algorithmic approach to testing.

Neurodevelopmental disorders - Insights

Learn more about how chromosomal microarray can be used as a first-tier diagnostic test for those with congenital abnormalities and developmental disabilities.

Confirmatory testing - Insights

Use of mass spectrometry technology in Mayo Clinic Laboratories’ confirmatory drug testing enables accurate identification of parent drugs and metabolites, equipping providers with confidence about their patients’ drug use.

Stimulants - Insights

Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.

Chain of custody drug testing - Insights

Chain of custody testing at Mayo Clinic Laboratories is performed on urine, serum, and meconium and adheres to the highest quality standards to provide secure results.

Therapeutic drug monitoring - Insights

Learn more about Mayo Clinic Laboratories’ clinically driven approach to therapeutic drug monitoring.

Membranous nephropathy - Insights

Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.

Hereditary causes of kidney stones - Insights

Learn about our kidney stone panel, which assesses 72 genes associated with inherited conditions that can lead to stone development.